{"count": 7, "results": [{"_id": "34692306", "pmid": 34692306, "pmcid": "PMC8525664", "title": "The Effectiveness of Statins as Potential Therapy for Multiple Sclerosis: A Systematic Review of Randomized Controlled trials", "journal": "Cureus", "authors": ["Abdalla MA", "Zakhary CM", "Rushdi H", "Hamdan JA", "Youssef KN", "Khan A", "Khan S"], "date": "2021-09-19T00:00:00Z", "doi": "10.7759/cureus.18092", "meta_date_publication": "2021 Sep", "meta_volume": "13", "meta_issue": "9", "meta_pages": "e18092", "score": 50278.75, "text_hl": "Summary of the statins use outcomes in @<m>DISEASE_Optic_Neuritis</m> @DISEASE_MESH:D009902 @@@optic neuritis@@@: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ used in @<m>DISEASE_Optic_Neuritis</m> @DISEASE_MESH:D009902 @@@optic neuritis@@@ showed significant benefits on the visual acuity, color perception, visual evoked potential (VEP) latency and VEP amplitude in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ arm compared to placebo. ", "citations": {"NLM": "Abdalla MA, Zakhary CM, Rushdi H, Hamdan JA, Youssef KN, Khan A, Khan S. The Effectiveness of Statins as Potential Therapy for Multiple Sclerosis: A Systematic Review of Randomized Controlled trials Cureus. 2021 Sep;13(9):e18092. PMID: 34692306", "BibTeX": "@article{34692306, title={The Effectiveness of Statins as Potential Therapy for Multiple Sclerosis: A Systematic Review of Randomized Controlled trials}, author={Abdalla MA and Zakhary CM and Rushdi H and Hamdan JA and Youssef KN and Khan A and Khan S}, journal={Cureus}, volume={13}, number={9}, pages={e18092}}"}}, {"_id": "22801929", "pmid": 22801929, "title": "Simvastatin in acute optic neuritis.", "journal": "Mult Scler", "authors": ["Johnson MA", "Cadavid D"], "date": "2012-11-01T00:00:00Z", "doi": "10.1177/1352458512452922", "meta_date_publication": "2012 Nov", "meta_volume": "18", "meta_issue": "11", "meta_pages": "1657; author reply 1658", "score": 50096.59, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in acute @<m>DISEASE_Optic_Neuritis</m> @DISEASE_MESH:D009902 @@@optic neuritis@@@.", "citations": {"NLM": "Johnson MA, Cadavid D. Simvastatin in acute optic neuritis. Mult Scler. 2012 Nov;18(11):1657; author reply 1658. PMID: 22801929", "BibTeX": "@article{22801929, title={Simvastatin in acute optic neuritis.}, author={Johnson MA and Cadavid D}, journal={Mult Scler}, volume={18}, number={11}, pages={1657; author reply 1658}}"}}, {"_id": "27165274", "pmid": 27165274, "title": "[Immunomodulation and neuroprotection in optic neuritis].", "journal": "Ophthalmologe", "authors": ["Beisse F", "Diem R"], "date": "2016-05-01T00:00:00Z", "doi": "10.1007/s00347-016-0264-2", "meta_date_publication": "2016 May", "meta_volume": "113", "meta_issue": "5", "meta_pages": "398-401", "score": 50079.887, "text_hl": "CONCLUSION: According to the data from recent treatment trials, there is hope that @DISEASE_Nerve_Degeneration @DISEASE_MESH:D009410 @@@neuronal loss@@@ in @<m>DISEASE_Optic_Neuritis</m> @DISEASE_MESH:D009902 @@@ON@@@ can be reduced with the help of immunomodulatory substances, such as @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or neuroprotective agents, such as @CHEMICAL_Memantine @CHEMICAL_MESH:D008559 @@@memantine@@@ and @GENE_EPO @GENE_2056 @@@erythropoietin@@@.", "citations": {"NLM": "Beisse F, Diem R. [Immunomodulation and neuroprotection in optic neuritis]. Ophthalmologe. 2016 May;113(5):398-401. PMID: 27165274", "BibTeX": "@article{27165274, title={[Immunomodulation and neuroprotection in optic neuritis].}, author={Beisse F and Diem R}, journal={Ophthalmologe}, volume={113}, number={5}, pages={398-401}}"}}, {"_id": "21921071", "pmid": 21921071, "title": "Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.", "journal": "Mult Scler", "authors": ["Tsakiri A", "Kallenbach K", "Fuglø D", "Wanscher B", "Larsson H", "Frederiksen J"], "date": "2012-01-01T00:00:00Z", "doi": "10.1177/1352458511415452", "meta_date_publication": "2012 Jan", "meta_volume": "18", "meta_issue": "1", "meta_pages": "72-81", "score": 50078.69, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ improves final visual outcome in acute @<m>DISEASE_Optic_Neuritis</m> @DISEASE_MESH:D009902 @@@optic neuritis@@@: a randomized study.", "citations": {"NLM": "Tsakiri A, Kallenbach K, Fuglø D, Wanscher B, Larsson H, Frederiksen J. Simvastatin improves final visual outcome in acute optic neuritis: a randomized study. Mult Scler. 2012 Jan;18(1):72-81. PMID: 21921071", "BibTeX": "@article{21921071, title={Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.}, author={Tsakiri A and Kallenbach K and Fuglø D and Wanscher B and Larsson H and Frederiksen J}, journal={Mult Scler}, volume={18}, number={1}, pages={72-81}}"}}, {"_id": "28075212", "pmid": 28075212, "title": "Response to Letter to the Editor 'Simvastatin improves final visual outcome in acute optic neuritis, a randomized study'.", "journal": "Mult Scler", "authors": ["Tsakiri A"], "date": "2012-11-01T00:00:00Z", "doi": "10.1177/1352458512452926", "meta_date_publication": "2012 Nov", "meta_volume": "18", "meta_issue": "11", "meta_pages": "1658", "score": 50074.09, "text_hl": "Response to Letter to the Editor '@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ improves final visual outcome in acute @<m>DISEASE_Optic_Neuritis</m> @DISEASE_MESH:D009902 @@@optic neuritis@@@, a randomized study'.", "citations": {"NLM": "Tsakiri A. Response to Letter to the Editor 'Simvastatin improves final visual outcome in acute optic neuritis, a randomized study'. Mult Scler. 2012 Nov;18(11):1658. PMID: 28075212", "BibTeX": "@article{28075212, title={Response to Letter to the Editor 'Simvastatin improves final visual outcome in acute optic neuritis, a randomized study'.}, author={Tsakiri A}, journal={Mult Scler}, volume={18}, number={11}, pages={1658}}"}}, {"_id": "19948167", "pmid": 19948167, "title": "Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin.", "journal": "Exp Neurol", "authors": ["Tsakiri A", "Tsiantoulas D", "Frederiksen J", "Svane IM"], "date": "2010-02-01T00:00:00Z", "doi": "10.1016/j.expneurol.2009.11.014", "meta_date_publication": "2010 Feb", "meta_volume": "221", "meta_issue": "2", "meta_pages": "320-8", "score": 50072.48, "text_hl": "Increased immunopotency of monocyte derived dendritic cells from @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Optic_Neuritis</m> @DISEASE_MESH:D009902 @@@optic neuritis@@@ is inhibited in vitro by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@.", "citations": {"NLM": "Tsakiri A, Tsiantoulas D, Frederiksen J, Svane IM. Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin. Exp Neurol. 2010 Feb;221(2):320-8. PMID: 19948167", "BibTeX": "@article{19948167, title={Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin.}, author={Tsakiri A and Tsiantoulas D and Frederiksen J and Svane IM}, journal={Exp Neurol}, volume={221}, number={2}, pages={320-8}}"}}, {"_id": "27035900", "pmid": 27035900, "title": "Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.", "journal": "Curr Opin Neurol", "authors": ["Aktas O", "Albrecht P", "Hartung HP"], "date": "2016-06-01T00:00:00Z", "doi": "10.1097/WCO.0000000000000327", "meta_date_publication": "2016 Jun", "meta_volume": "29", "meta_issue": "3", "meta_pages": "199-204", "score": 50055.066, "text_hl": "RECENT FINDINGS: @<m>DISEASE_Optic_Neuritis</m> @DISEASE_MESH:D009902 @@@Optic neuritis@@@ has been used in a series of recent pilot studies investigating the effects of @GENE_EPO @GENE_2056 @@@erythropoietin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, autologous mesenchymal stem cells, @CHEMICAL_Phenytoin @CHEMICAL_MESH:D010672 @@@phenytoin@@@, as well as blockade of @GENE_LINGO1 @GENE_84894 @@@LINGO-1@@@ (@CHEMICAL_opicinumab @CHEMICAL_MESH:C000625770 @@@opicinumab@@@). ", "citations": {"NLM": "Aktas O, Albrecht P, Hartung HP. Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives. Curr Opin Neurol. 2016 Jun;29(3):199-204. PMID: 27035900", "BibTeX": "@article{27035900, title={Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.}, author={Aktas O and Albrecht P and Hartung HP}, journal={Curr Opin Neurol}, volume={29}, number={3}, pages={199-204}}"}}]}